BMO Capital Markets Reiterates Outperform Rating for Genmab AS
| GMAB Stock | USD 21.16 0.51 2.47% |
About 55% of Genmab AS's investors are presently thinking to get in. The analysis of overall sentiment of trading Genmab AS stock suggests that some investors are interested at this time. The current market sentiment, together with Genmab AS's historical and current headlines, can help investors time the market. In addition, many technical investors use Genmab AS stock news signals to limit their universe of possible portfolio assets.
Genmab |
BMO Capital Markets reiterated their outperform rating on shares of Genmab AS in a report published on Friday,Benzinga reports. They currently have a 48.00 price objective on the stock, up from their previous price objective of 46.00. GMAB has been the subject of a number of other reports. JPMorgan Chase
Read at thelincolnianonline.com
 |
Genmab AS Fundamental Analysis
We analyze Genmab AS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Genmab AS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Genmab AS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Target Price
Target Price Comparative Analysis
Genmab AS is currently under evaluation in target price category among its peers.
Genmab AS Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Genmab AS stock to make a market-neutral strategy. Peer analysis of Genmab AS could also be used in its relative valuation, which is a method of valuing Genmab AS by comparing valuation metrics with similar companies.
Peers
Genmab AS Related Equities
| TERN | Terns Pharmaceuticals | 7.82 | ||||
| BGNE | BeiGene | 7.31 | ||||
| AMLX | Amylyx Pharmaceuticals | 5.32 | ||||
| APLS | Apellis Pharmaceuticals | 4.63 | ||||
| AKRO | Akero Therapeutics | 3.24 | ||||
| PCVX | Vaxcyte | 2.77 | ||||
| DAWN | Day One | 1.33 | ||||
| LEGN | Legend Biotech | 1.29 | ||||
| ASND | Ascendis Pharma | 1.28 | ||||
| BPMC | Blueprint Medicines | 0.50 | ||||
| CYTK | Cytokinetics | 0.38 | ||||
| EWTX | Edgewise Therapeutics | 0.37 | ||||
| ALEC | Alector | 0.78 | ||||
| TVTX | Travere Therapeutics | 1.89 |
Complementary Tools for Genmab Stock analysis
When running Genmab AS's price analysis, check to measure Genmab AS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genmab AS is operating at the current time. Most of Genmab AS's value examination focuses on studying past and present price action to predict the probability of Genmab AS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genmab AS's price. Additionally, you may evaluate how the addition of Genmab AS to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |